@article{PAR00011682,
  title = {{X}pert {F}lu for point-of-care diagnosis of human influenza in industrialized countries},
  author = {{S}alez, {N}. and {N}ougairede, {A}. and {N}inove, {L}. and {Z}andotti, {C}. and de {L}amballerie, {X}avier and {C}harrel, {R}. {N}.},
  editor = {},
  language = {{ENG}},
  abstract = {{R}espiratory infections, particularly those caused by influenza viruses, represent the third-most important cause of death in the world due to infectious diseases. {N}evertheless, despite the enormous publicity attracted by epidemics due to these viruses, laboratory diagnosis, documentation and recording of respiratory diseases is still unsatisfactory. {A}vailable diagnostic tests capable of providing results rapidly are either limited and insufficiently sensitive or highly sensitive and specific but insufficiently rapid. {C}onsiderable investment and research efforts have been made towards the development of new diagnostics for influenza {A} and {B} viruses and the {X}pert(({R})) {F}lu assay ({C}epheid(({R})), {CA}, {USA}) has emerged as one of the most promising. {I}n this article, we review current knowledge of the {X}pert {F}lu test, discuss its potential value as a point-of-care test and outline the potential leads for future development.},
  keywords = {point-of-care ; influenza {A} ; diagnosis ; respiratory infection ; influenza {B} ; molecular diagnostics ; {PCR}},
  booktitle = {},
  journal = {{E}xpert {R}eview of {M}olecular {D}iagnostics},
  volume = {14},
  numero = {4},
  pages = {411--418},
  ISSN = {1473-7159},
  year = {2014},
  DOI = {10.1586/14737159.2014.901152},
  URL = {https://www.documentation.ird.fr/hor/{PAR}00011682},
}